Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.905 USD | -2.86% | +4.96% | +648.60% |
May. 31 | Piper Sandler Starts Elevation Oncology With Overweight Rating, $10 Price Target | MT |
May. 14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+648.60% | 220M | |
+14.00% | 118B | |
+13.41% | 106B | |
-1.95% | 24.28B | |
+0.70% | 21.96B | |
-9.03% | 18.16B | |
-42.12% | 16.37B | |
-17.41% | 15.56B | |
+4.89% | 13.63B | |
+31.06% | 12.27B |
- Stock Market
- Equities
- ELEV Stock
- News Elevation Oncology, Inc.
- JPMorgan Downgrades Elevation Oncology to Neutral from Overweight